A well-designed randomized clinical trial (RCT) is widely considered the most reliable approach for evaluating the efficacy of clinical interventions or assessing the probable benefit of a medical device. However, RCTs often face practical limitations, such as difficulties in accruing patients, or other logistical or feasibility issues. As a result, alternative methods for the evaluation of treatments are increasingly considered, such as the assessment of a health interventions’ effects in nonrandomized, observational studies.
1 Although such evaluations often provide results similar to those seen in RCTs,
2,3 exceptions are not uncommon.
4 The main concern about non-RCTs is that it is currently challenging to predict with confidence when the results of RCTs will be concordant with those of observational studies. The consequences of such a discordance can sometimes be disastrous.
5,6